ISIN | LU2721086416 |
---|---|
Valorennummer | |
Bloomberg Global ID | |
Fondsname | Bellevue Funds (Lux) - Bellevue AI Health Bellevue Funds (Lux) - Bellevue AI Health B |
Fondsanbieter |
Bellevue Asset Management AG
Zürich, Schweiz Telefon: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fondsanbieter | Bellevue Asset Management AG |
Vertreter in der Schweiz |
Waystone Fund Services (Switzerland) SA Lausanne Telefon: 0041213111781 |
Distributor(en) | |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
Investment-Strategie *** | The Sub-fund is an actively managed equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of Bellevue AI Health in a portfolio of carefully chosen shares and preference shares of companies whose business activities have a strong focus on the provision and/or use of artificial intelligence (AI) in the health sector or whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. |
Besonderheiten |
Aktueller Preis * | 144.62 EUR | 07.11.2024 |
---|---|---|
Vorheriger Preis * | 144.57 EUR | 06.11.2024 |
52 Wochen Hoch * | 152.18 EUR | 30.08.2024 |
52 Wochen Tief * | 132.25 EUR | 24.01.2024 |
NAV * | 144.62 EUR | 07.11.2024 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 10'358'378 | |
Anteilsklassevermögen *** | ||
Trading Information SIX |
YTD-Performance | - | - |
---|---|---|
YTD-Performance (in CHF) | - | - |
1 Monat | -0.73% |
07.10.2024 - 07.11.2024
07.10.2024 07.11.2024 |
3 Monate | +2.08% |
07.08.2024 - 07.11.2024
07.08.2024 07.11.2024 |
6 Monate | +3.94% |
07.05.2024 - 07.11.2024
07.05.2024 07.11.2024 |
1 Jahr | +9.35% |
24.01.2024 - 07.11.2024
24.01.2024 07.11.2024 |
2 Jahre | - | - |
3 Jahre | - | - |
5 Jahre | - | - |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 8.96% | |
---|---|---|
UnitedHealth Group Inc | 7.93% | |
Novo Nordisk AS Class B | 4.95% | |
Johnson & Johnson | 4.32% | |
AbbVie Inc | 4.15% | |
Amgen Inc | 4.04% | |
Merck & Co Inc | 3.91% | |
Roche Holding AG | 3.46% | |
AstraZeneca PLC | 3.25% | |
Novartis AG Registered Shares | 3.16% | |
Letzte Daten-Aktualisierung | 30.09.2024 |
TER *** | 2.41% |
---|---|
Datum TER *** | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.60% |
Ongoing Charges *** | |
SRRI ***
|
|
Datum SRRI *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |